Possible harms depend on the product and procedure. They can include reactions at collection or administration sites, infection and unwanted immune responses; transplant programmes have a different risk profile from local injections. The US FDA has reported serious harms with unapproved regenerative products. US FDA: regenerative medicine patient information. Ask for product-specific information and written aftercare instructions. Read side effects and urgent-care guidance.
On this page
Obtain instructions for the actual procedure
Ask the clinician to distinguish effects from cell collection, administration, the preparation and other medicines. Obtain a written contact and escalation plan for after you leave the facility. Report new symptoms using the treatment date and product details rather than assuming discomfort is a sign that the procedure is working.
Questions to take to a consultation
- Which effects are expected and for how long?
- Which symptoms need urgent assessment?
- Who will review a concern after I return home?
Request clear written answers and discuss unresolved points with a clinician familiar with your history before committing to a product or procedure.
Related questions
- What is a risk of using stem cells?
- Can stem cells turn cancerous?
- Who is not a candidate for stem cell therapy?
Return to the FAQ index to browse all questions and the detailed decision guides.
Ask about an assessment
For questions about the review process, availability or a written estimate, message Thailand Stem Cell Clinic. Ask how to share records securely. An enquiry does not confirm eligibility or that a particular treatment is offered.
All FAQs · Treatment guides · Contact information
Sources and further reading
General information, not an individual medical recommendation. Prices, coverage, eligibility and authorisation require case-specific confirmation. Source links describe their own research and jurisdictions.